Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00034627
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
32T | (S)-2-AMINO-3-(4H-THIENO[3,2-B]- PYRROL-6-YL)-PROPIONIC ACID | A | 1RMO | 0.72 | |
MZ8 | N-{(1S,2R)-3-[(1,3-BENZOTHIAZOL- 6-YLSULFONYL)(ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYL}-3-HYDROXYBENZAMIDE | A,B | 2QI6 | 0.74 | |
RWJ | CYCLOPENTANECARBOXYLIC ACID [1- (BENZOTHIAZOLE-2-CARBONYL)-4-GUANIDINO- BUTYL]-AMIDE | A | 1QCP | 0.7 | |
LS2 | N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO- 8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE | A | 1KE6 | 0.7 | |
815 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1- (1-AMINO-ISOQUINOLIN-7-YLMETHYL)- 2-OXO-PYRROLDIN-3-YL]-AMIDE | A | 1F0R | 0.71 | |
RIT | RITONAVIR | A,B | 2B60 | 0.75 | |
RIT | RITONAVIR | B,D | 1N49 | 0.75 | |
RIT | RITONAVIR | A | 1RL8 | 0.75 | |
RIT | RITONAVIR | B | 1SH9 | 0.75 | |
RIT | RITONAVIR | B | 1HXW | 0.75 | |
685 | 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin- 4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]- 4-methyl-1,3-thiazole-5-carboxamide | A | 3EMG | 0.71 | |
B97 | (10R)-10-methyl-3-(6-methylpyridin- 3-yl)-9,10,11,12-tetrahydro-8H- [1,4]diazepino[5',6':4,5]thieno[3,2- f]quinolin-8-one | X | 3FYJ | 0.71 | |
MZ7 | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.79 | |
GGW | methyl [(1S,4S,5S,7S,10S)-4-benzyl- 1,10-di-tert-butyl-5-hydroxy-2,9,12- trioxo-7-(4-pyridin-2-ylbenzyl)- 13-oxa-3,8,11-triazatetradec-1- yl]carbamate | H | 3GGA | 0.71 | |
MZ5 | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.8 | |
PR2 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2- OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN- 2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE | A | 1F0S | 0.7 | |
SRS | 4-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.0(13,18)]NONADECA- 12(19),13(18),15,17-TETRAENE-10- CARBAMOYL)PENTA-METHYLSULFONEDIIMINE | A | 1MMR | 0.71 | |
I10 | 1-[2-(3-BIPHENYL)-4-METHYLVALERYL)]AMINO- 3-(2-PYRIDYLSULFONYL)AMINO-2-PROPANONE | A | 1BGO | 0.74 | |
PF3 | (2R)-3-({[4-[(PYRIDIN-4-YL)PHENYL]- THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID | A,B | 1UTZ | 0.77 | |
MZ6 | N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-3-HYDROXYBENZAMIDE | A,B | 2QI4 | 0.74 | |
PR1 | 4-HYDROXY-3-[2-OXO-3-(THIENO[3,2- B]PYRIDINE-2-SULFONYLAMINO)-PYRROLIDIN- 1-YLMETHYL]-BENZAMIDINE | A | 1F0T | 0.71 | |
737 | N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)- BUTYL]-2-{6-OXO-5-[(QUINOLIN-8- YLMETHYL)-AMINO]-2-M-TOLYL-6H-PYRIMIDIN- 1-YL}-ACETAMIDE | A | 1ZTL | 0.71 | |
OIS | (S)-N-((2S,3R)-3-HYDROXY-4-(4-((E)- (HYDROXYIMINO)METHYL)-N-ISOBUTYLPHENYLSULFONAMIDO)- 1-PHENYLBUTAN-2-YL)-3-METHYL-2- (3-((2-METHYLTHIAZOL-4-YL)METHYL)- 2-OXOIMIDAZOLIDIN-1-YL)BUTANAMIDE | A | 1YT9 | 0.72 |